Osage University Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 14
- Investments
- 195
- Portfolio
- 57
- Exits
- 63
Osage University Partners General Information
Description
Established in 2009, Osage University Partners is a venture capital firm based in Bala Cynwyd, Pennsylvania. The firm prefers to invest in software, hardware, therapeutics, medical devices, and diagnostics sectors with a focus on startups that are commercializing university technologies.
Contact Information
Website
oup.vc
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 50 Monument Road
- Suite 201
- Bala Cynwyd, PA 19004
- United States
+1 (484) 000-0000
Osage University Partners Investments (195)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| IMMvention Therapeutix | 19-Nov-2021 | Seed Round | 00.00 | Drug Discovery | Pre-Clinical Trials | 0000000 00000 00.0 |
| 00000 000000000000 | 08-Nov-2021 | 0000 | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | |
| 000000 00000000000 | 02-Nov-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 000000 00000000000 | 13-Oct-2021 | 00000 00000 | 0000 | Drug Delivery | Generating Revenue | |
| 000000 00000000 | 12-Oct-2021 | 00000 00000 | 00000 | Biotechnology | Startup | |
| 000000 000 | 14-Sep-2021 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 000000000 | 02-Sep-2021 | 00000 00000 | 0000 | Network Management Software | Generating Revenue | |
| 0000 000000000 | 21-Aug-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| Sonoma Biotherapeutics | 04-Aug-2021 | Early Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | |
| Ribon Therapeutics | 14-Jul-2021 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 0000000000 00 |
Osage University Partners Exits (63)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| StreetLight Data | 07-Feb-2022 | Merger/Acquisition | |
| 0000 | 30-Sep-2021 | 0000000 000000 | 00000 |
| 0000 000000000 | 15-Sep-2021 | 000 | 00000 |
| 00000000 000000000 | 26-Aug-2021 | 0000000 000000 | 00000 |
| 000000 | 10-Aug-2021 | 000000000000000000 | |
| 00000000000 | 27-Jul-2021 | 000000000000000000 | |
| 00000 0000000000 | 19-Jul-2021 | 0000000 000000 | 00000 |
| 0000 00000000000 | 15-Jul-2021 | 000 | 0000 |
| Aerovate Therapeutics | 30-Jun-2021 | IPO | 00000 |
| Graphite Bio | 25-Jun-2021 | IPO | 00000 |
Osage University Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialOsage University Partners Team (26)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Marc Singer | Co-Founder & Managing Partner, Technology | 00 | 0 | 0 | Bala Cynwyd, PA |
| William Harrington MD | Managing Partner, Life Science | 00 | 0 | 0 | Bala Cynwyd, PA |
| Matthew Cohen Ph.D | Partner, Life Science | 0 | 0 | 0 | Bala Cynwyd, PA |
| Kirsten Leute | Partner, University Relations | Bala Cynwyd, PA | |||
| Anurag Agarwal Ph.D | Principal, Life Science | Bala Cynwyd, PA |
Osage University Partners Co-Investors (354)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 11 | 0 | 0 |
|
|
| RA Capital Management | 0 | 0 | 0 |
|
|
| Cormorant Asset Management | 0 | 0 | 0 |
|
|
| Alexandria Venture Investments | 0 | 0 |
|
|
|
| Johnson & Johnson Innovation - JJDC | 0 | 0 |
|
|